miRNA profiling in vitreous humor, vitreal exosomes and serum from uveal melanoma patients: Pathological and diagnostic implications

Cancer Biology and Therapy

Volumn 16, Issue 9, 2015, Pages 1387-1396

  Ragusa, Marco ^a   Barbagallo, Cristina ^a   Statello, Luisa ^a   Caltabiano, Rosario ^a   Russo, Andrea ^a   Puzzo, Lidia ^a   Avitabile, Teresio ^a   Longo, Antonio ^a   Toro, Mario D ^a   Barbagallo, Davide ^a   Valadi, Hadi ^b   Di Pietro, Cinzia ^a   Purrello, Michele ^a   Reibaldi, Michele ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

exosomes, microRNAs, serum, uveal melanoma, vitreous humor

Indexed keywords

BIOLOGICAL MARKER; FORMALDEHYDE; MICRORNA; MICRORNA 146A; MICRORNA 21; MICRORNA 34A; PARAFFIN; TRANSCRIPTOME; TUMOR MARKER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EXOSOME; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; MOLECULAR DIAGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SERUM; STATISTICAL ANALYSIS; UVEA MELANOMA; VITREOUS BODY; BLOOD; CASE CONTROL STUDY; GENETICS; MELANOMA; METABOLISM; MIDDLE AGED; SECRETION (PROCESS); UVEAL NEOPLASMS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; EXOSOMES; FEMALE; HUMANS; MALE; MELANOMA; MICRORNAS; MIDDLE AGED; TRANSCRIPTOME; UVEAL NEOPLASMS; VITREOUS BODY;

EID: 84941806468     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.1080/15384047.2015.1046021     Document Type: Article

References (48)

1. M.A.Materin, M.Faries, H.M.Kluger. Molecular alternations in uveal melanoma. Curr Probl Cancer 2011; 35(4):211-24; PMID:21911184; http://dx.doi.org/10.1016/j.currproblcancer.2011.07.004
2. C.C.McLaughlin, X.C.Wu, A.Jemal, H.J.Martin, L.M.Roche, V.W.Chen. Incidence of noncutaneous melanomas in the U.S. 2005; Cancer. 103:1000-7; PMID:15651058
3. S.Dithmar, C.E.Diaz, H.E.Grossniklaus. Intraocular melanoma spread to regional lymph nodes: report of two cases. Retina 2000; 20:76-9; PMID:10696752; http://dx.doi.org/10.1097/00006982-200001000-00014
4. E.1.Kujala, T.Mäkitie, T.Kivelä. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci 2003; 44(11):4651-9; PMID:14578381; http://dx.doi.org/10.1167/iovs.03-0538
5. A.D.Singh, A.Topham. Survival rates with uveal melanoma in the United States:1973-1997. Ophthalmology 2003; 110(5):962-5; PMID:12750098; http://dx.doi.org/10.1016/S0161-6420(03)00077-0
6. W.Yang, S.Hu, J.Wang, L.Wang, B.Zheng. Color Doppler imaging diagnosis of intra-ocular tumor. Chin Med J (Engl) 1997; 110(9):664-6; PMID:9642319
7. X.Chen, Y.Ba, L.Ma, X.Cai, Y.Yin, K.Wang, J.Guo, Y.Zhang, J.Chen, X.Guo, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008; 18(10):997-1006; PMID:18766170; http://dx.doi.org/10.1038/cr.2008.282
8. S.Gilad, E.Meiri, Y.Yogev, S.Benjamin, D.Lebanony, N.Yerushalmi, H.Benjamin, M.Kushnir, H.Cholakh, N.Melamed, et al. Serum microRNAs are promising novel biomarkers. PLoS One 2008; 3(9):e3148; PMID:18773077; http://dx.doi.org/10.1371/journal.pone.0003148
9. P.S.Mitchell, R.K.Parkin, E.M.Kroh, B.R.Fritz, S.K.Wyman, E.L.Pogosova-Agadjanyan, A.Peterson, J.Noteboom, K.C.O'Briant, A.Allen, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008; 105(30):10513-8; PMID:18663219; http://dx.doi.org/10.1073/pnas.0804549105
10. N.Kosaka, H.Iguchi, T.Ochiya. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci 2010; 101(10):2087-92; PMID:20624164; http://dx.doi.org/10.1111/j.1349-7006.2010.01650.x
11. H.Valadi, K.Ekström, A.Bossios, M.Sjöstrand, J.J.Lee, J.O.Lötvall. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9(6):654-9; PMID:17486113; http://dx.doi.org/10.1038/ncb1596
12. C.Corrado, S.Raimondo, A.Chiesi, F.Ciccia, G.De Leo, R.Alessandro. Exosomes as intercellular signaling organelles involved in health and disease: basic science and clinical applications. Int J Mol Sci 2013; 14(3):5338-66; PMID:23466882; http://dx.doi.org/10.3390/ijms14035338
13. A.Hendrix, W.Westbroek, M.Bracke, O.De Wever. An ex(o)citing machinery for invasive tumor growth. Cancer Res 2010; 70(23):9533-7; PMID:21098711; http://dx.doi.org/10.1158/0008-5472.CAN-10-3248
14. M.Ragusa, R.Caltabiano, A.Russo, L.Puzzo, T.Avitabile, A.Longo, M.D.Toro, C.Di Pietro, M.Purrello, M.Reibaldi. MicroRNAs in vitreus humor from patients with ocular diseases. Mol Vis 2013; 19:430-40; PMID:23441115
15. T.Blondal, S.Jensby Nielsen, A.Baker, D.Andreasen, P.Mouritzen, M.Wrang Teilum, I.K.Dahlsveen. Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods 2013; 59(1):S1-6; PMID:23036329; http://dx.doi.org/10.1016/j.ymeth.2012.09.015
16. M.Pacifici, S.Delbue, F.Kadri, F.Peruzzi. Cerebrospinal fluid MicroRNA profiling using quantitative real time PCR. J Vis Exp 2014; (83):e51172; PMID:24514260
17. N.Kosaka, Y.Yoshioka, K.Hagiwara, N.Tominaga, T.Katsuda, T.Ochiya. Trash or Treasure: extracellular microRNAs and cell-to-cell communication. Front Genet 2013; 4:173; PMID:24046777; http://dx.doi.org/10.3389/fgene.2013.00173
18. M.Y.Shah, G.A.Calin. The mix of two worlds: non-coding RNAs and hormones. Nucleic Acid Ther 2013; 23(1):2-8; PMID:23051203
19. R.A.Boon, K.C.Vickers. Intercellular transport of microRNAs. Arterioscler Thromb Vasc Biol 2013; 33(2):186-92; PMID:23325475; http://dx.doi.org/10.1161/ATVBAHA.112.300139
20. A.Turchinovich, L.Weiz, A.Langheinz, B.Burwinkel. Characterization of extracellular circulating microRNA. Nucleic Acids Res 2011; 39(16):7223-33; PMID:21609964; http://dx.doi.org/10.1093/nar/gkr254
21. K.C.Vickers, A.T.Remaley. Lipid-based carriers of microRNAs and intercellular communication. Curr Opin Lipidol 2012; 23(2):91-7; PMID:22418571; http://dx.doi.org/10.1097/MOL.0b013e328350a425
22. G.Di Leva, C.M.Croce. miRNA profiling of cancer. Curr Opin Genet Dev 2013 23(1):3-11; PMID:23465882; http://dx.doi.org/10.1016/j.gde.2013.01.004
23. O.Fortunato, M.Boeri, C.Verri, D.Conte, M.Mensah, P.Suatoni, U.Pastorino, G.Sozzi. Assessment of circulating microRNAs in plasma of lung cancer patients. Molecules 2014; 19(3):3038-54; PMID:24619302; http://dx.doi.org/10.3390/molecules19033038
24. G.A.Ganepola, J.R.Rutledge, P.Suman, A.Yiengpruksawan, D.H.Chang. Novel blood-based microRNA biomarker panel for early diagnosis of pancreatic cancer. World J Gastrointest Oncol 2014; 6(1):22-33; PMID:24578785; http://dx.doi.org/10.4251/wjgo.v6.i1.22
25. F.Mar-Aguilar, C.Rodríguez-Padilla, D.Reséndez-Pérez. Use of serum-circulating miRNA profiling for the identification of breast cancer biomarkers. Methods Mol Biol 2014; 1165:71-80; PMID:24839019; http://dx.doi.org/10.1007/978-1-4939-0856-1_6
26. J.Wang, S.K.Huang, M.Zhao, M.Yang, J.L.Zhong, Y.Y.Gu, H.Peng, Y.Q.Che, C.Z.Huang. Identification of a circulating microRNA signature for colorectal cancer detection. PLoS One 2014; 9(4):e87451; PMID:24709885; http://dx.doi.org/10.1371/journal.pone.0087451
27. H.Ando, Y.Niki, M.Ito, K.Akiyama, M.S.Matsui, D.B.Yarosh, M.Ichihashi. Melanosomes are transferred from melanocytes to keratinocytes through the processes of packaging, release, uptake, and dispersion. J Invest Dermatol 2012; 132(4):1222-9; PMID:22189785; http://dx.doi.org/10.1038/jid.2011.413
28. R.Crescitelli, C.Lässer, T.G.Szabó, A.Kittel, M.Eldh, I.Dianzani, E.I.Buzás, J.Lötvall. Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes. J Extracell Vesicles 2013; 12:2; PMID:24223256
29. H.Kalra, R.J.Simpson, H.Ji, E.Aikawa, P.Altevogt, P.Askenase, V.C.Bond, F.E.Borràs, X.Breakefield, V.Budnik, et al. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol 2012; 10(12):e1001450; PMID:23271954; http://dx.doi.org/10.1371/journal.pbio.1001450
30. P.Filipazzi, M.Bürdek, A.Villa, L.Rivoltini, V.Huber. Recent advances on the role of tumor exosomes in immunosuppression and disease progression. Semin Cancer Biol 2012; 22(4):342-9; PMID:22369922; http://dx.doi.org/10.1016/j.semcancer.2012.02.005
31. C.Yang, P.D.Robbins. The roles of tumor-derived exosomes in cancer pathogenesis. Clin Dev Immunol 2011; 2011:842849; PMID:22190973
32. D.Xiao, J.Ohlendorf, Y.Chen, D.D.Taylor, S.N.Rai, S.Waigel, W.Zacharias, H.Hao, K.M.McMasters. Identifying mRNA, microRNA and protein profiles of melanoma exosomes. PLoS One 2012; 7(10):e46874; PMID:23056502; http://dx.doi.org/10.1371/journal.pone.0046874
33. S.Gaudi, J.L.Messina. Molecular bases of cutaneous and uveal melanomas. Patholog Res Int 2011; 2011:159421; PMID:21876842
34. S.Achberger, W.Aldrich, R.Tubbs, J.W.Crabb, A.D.Singh, P.L.Triozzi. Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic disease. Mol Immunol 2014; 58(2):182-6; PMID:24370793; http://dx.doi.org/10.1016/j.molimm.2013.11.018
35. M.P.Boldin, K.D.Taganov, D.S.Rao, L.Yang, J.L.Zhao, M.Kalwani, Y.Garcia-Flores, M.Luong, A.Devrekanli, J.Xu, et al. MiR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J Exp Med 2011; 208(6):1189-201; PMID:21555486; http://dx.doi.org/10.1084/jem.20101823
36. J.H.Paik, J.Y.Jang, Y.K.Jeon, W.Y.Kim, T.M.Kim, D.S.Heo, C.W.Kim. MicroRNA-146a downregulates NFκB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphoma. Clin Cancer Res 2011; 17(14):4761-71; PMID:21610143; http://dx.doi.org/10.1158/1078-0432.CCR-11-0494
37. F.J.Sheedy, L.A.O'Neill. Adding fuel to fire: microRNAs as a new class of mediators of inflammation. Ann Rheum Dis 2008; 67 3:iii50-5; PMID:19022814
38. R.Mastropasqua, L.Toto, F.Cipollone, D.Santovito, P.Carpineto, L.Mastropasqua. Role of microRNAs in the modulation of diabetic retinopathy. Prog Retin Eye Res 2014; 43C:92-107; PMID:25128741; http://dx.doi.org/10.1016/j.preteyeres.2014.07.003
39. M.Forloni, S.K.Dogra, Y.Dong, D.ConteJr, J.Ou, L.J.Zhu, A.Deng, M.Mahalingam, M.R.Green, N.Wajapeyee. miR-146a promotes the initiation and progression of melanoma by activating Notch signaling. Elife 2014; 3:e01460; PMID:24550252; http://dx.doi.org/10.7554/eLife.01460
40. M.D.Onken, L.A.Worley, M.D.Long, S.Duan, M.L.Council, A.M.Bowcock, J.W.Harbour. Oncogenic mutations in GNAQ occur early in uveal melanoma. Invest Ophthalmol Vis Sci 2008; 49(12):5230-4; PMID:18719078; http://dx.doi.org/10.1167/iovs.08-2145
41. X.Chen, J.Wang, H.Shen, J.Lu, C.Li, D.N.Hu, X.D.Dong, D.Yan, L.Tu. Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma. Invest Ophthalmol Vis Sci 2011; 52(3):1193-9; PMID:21051724; http://dx.doi.org/10.1167/iovs.10-5272
42. F.Ozsolak, L.L.Poling, Z.Wang, H.Liu, X.S.Liu, R.G.Roeder, X.Zhang, J.S.Song, D.E.Fisher. Chromatin structure analyses identify miRNA promoters. Genes Dev 2008; 22(22):3172-83; PMID:19056895; http://dx.doi.org/10.1101/gad.1706508
43. I.Yajima, M.Y.Kumasaka, N.D.Thang, Y.Goto, K.Takeda, M.Iida, N.Ohgami, H.Tamura, O.Yamanoshita, Y.Kawamoto, et al. Molecular Network Associated with MITF in Skin Melanoma Development and Progression. J Skin Cancer 2011; 2011:730170; PMID:22046555; http://dx.doi.org/10.1155/2011/730170
44. M.G.Field, J.W.Harbour. Recent developments in prognostic and predictive testing in uveal melanoma. Curr Opin Ophthalmol 2014; 25(3):234-9; PMID:24713608; http://dx.doi.org/10.1097/ICU.0000000000000051
45. A.B.Rashid, H.E.Grossniklaus. Clinical, pathologic, and imaging features and biological markers of uveal melanoma. Methods Mol Biol 2014; 1102:397-425; PMID:24258990; http://dx.doi.org/10.1007/978-1-62703-727-3_21
46. O.Simó-Servat, C.Hernández, R.Simó. Usefulness of the vitreous fluid analysis in the translational research of diabetic retinopathy. Mediators Inflamm 2012; 2012:872978
47. B.Damato, K.Lecuona. Conservation of eyes with choroidal melanoma by a multimodality approach to treatment: an audit of 1632 patients. Ophthalmology 2004; 111(5):977-83; PMID:15121377; http://dx.doi.org/10.1016/j.ophtha.2003.09.028
48. M.Ragusa, L.Statello, M.Maugeri, C.Barbagallo, R.Passanisi, M.S.Alhamdani, G.Li Destri, A.Cappellani, D.Barbagallo, M.Scalia, et al. Highly skewed distribution of miRNAs and proteins between colorectal cancer cells and their exosomes following Cetuximab treatment: biomolecular, genetic and translational implications. Oncoscience 2014; 1(2):132-157; PMID:25594007